James E Fickenscher Zynerba Pharmaceuticals, Inc. (ZYNE) insider trading activity

James E Fickenscher is Chief Financial Officer of Zynerba Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of ZYNE, which is worth approximately $0. The most recent transaction as insider was on Oct 10, 2023, when has been sold 548,087 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

James E Fickenscher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 10 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	548,087 Reduced 100.0%	0 Common Stock
Oct 10 2023	BUY Grant, award, or other acquisition	-	170,000 Added 28.57%	425,000 Common Stock
Sep 13 2023	SELL Open market or private sale	$11,967 $1.33 p/Share	8,998 Reduced 2.32%	378,087 Common Stock
Sep 12 2023	BUY Grant, award, or other acquisition	-	31,200 Added 7.46%	387,085 Common Stock
Feb 08 2023	SELL Payment of exercise price or tax liability	$3,926 $0.6 p/Share	6,544 Reduced 1.81%	355,885 Common Stock
Feb 07 2023	BUY Grant, award, or other acquisition	-	22,547 Added 5.86%	362,429 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$3,556 $0.6 p/Share	5,927 Reduced 1.71%	339,882 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	21,073 Added 5.74%	345,809 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	170,000 Added 34.36%	324,736 Common Stock
Jan 23 2023	SELL Open market or private sale	$10,661 $0.6 p/Share	17,769 Reduced 10.3%	154,736 Common Stock
Jul 19 2022	SELL Open market or private sale	$6,614 $1.1 p/Share	6,013 Reduced 3.37%	172,505 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	-	20,800 Added 10.44%	178,518 Common Stock
Jan 26 2022	BUY Grant, award, or other acquisition	-	85,000 Added 35.02%	157,718 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	52,000 Added 41.69%	72,718 Common Stock

JEF

James E Fickenscher

Chief Financial Officer

Devon, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYNE shares.

Notify only if

Value

Insider Trading

Get notified when an Zynerba Pharmaceuticals, Inc. insider buys or sells ZYNE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zynerba Pharmaceuticals, Inc.

Track Activities on ZYNE

Account